CLINICAL TRIALS PROFILE FOR CLINDAMYCIN PHOSPHATE AND TRETINOIN
✉ Email this page to a colleague
All Clinical Trials for Clindamycin Phosphate And Tretinoin
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00823901 ↗ | Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea | Completed | Medicis Pharmaceutical Corporation | Phase 2/Phase 3 | 2009-02-01 | The purpose of this study is to determine whether Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel are effective and safe in the treatment of papulopustular rosacea. |
NCT00823901 ↗ | Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea | Completed | Massachusetts General Hospital | Phase 2/Phase 3 | 2009-02-01 | The purpose of this study is to determine whether Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel are effective and safe in the treatment of papulopustular rosacea. |
NCT00838812 ↗ | Safety and Efficacy Study of Association Between Tretinoin and Clindamycin on the Treatment of Acne Mild and Moderate | Completed | Igefarma Laboratorios S.A. | Phase 3 | 2009-03-01 | The purpose of this study is to determine the safety and efficacy of association between tretinoin and clindamycin phosphate on the treatment of acne vulgaris mild and moderate. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Clindamycin Phosphate And Tretinoin
Condition Name
Clinical Trial Locations for Clindamycin Phosphate And Tretinoin
Trials by Country
Clinical Trial Progress for Clindamycin Phosphate And Tretinoin
Clinical Trial Phase
Clinical Trial Sponsors for Clindamycin Phosphate And Tretinoin
Sponsor Name